Nov 16 (Reuters) - Antibe Therapeutics Inc ATE.V :
* Enters into a gud product licensing agreement with Knight Therapeutics
* Says granted Knight the exclusive commercial rights for antibe's drug
candidates and other future prescription drugs
* Says Antibe is entitled to royalties on annual sales, along with the
potential for $10 million in payments
* Source text for Eikon ID:nBw6tqGyda
* Further company coverage ATE.V